<DOC>
	<DOCNO>NCT00179127</DOCNO>
	<brief_summary>The purpose study determine effect addition insulin glargine early phase moderate severe Diabetic Ketoacidosis ( DKA ) child . The investigator hypothesize addition insulin glargine early phase management DKA accelerate acidosis correction , decrease length insulin infusion , decrease total intensive care unit time child admit ICU .</brief_summary>
	<brief_title>Use Insulin Glargine Treat Diabetic Ketoacidosis</brief_title>
	<detailed_description />
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Ages 618 y.o . present VCH E.R . : Established history insulin dependent diabetes AND : Chief c/o hyperglycemia vomit Venous pH &lt; 7.24 Serum Bicarbonate &lt; 18 Blood glucose &gt; 150 Urinary Ketones Age &lt; 6y.o . New onset diabetes Received IV insulin bolus prior arrival VCH E.R . Venous pH &gt; 7.24 Serum Bicarbonate &gt; 18 Pregnancy Received glargine within 12 hour prior arrival VCH E.R./PCCU</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Pediatrics</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Emergency Care</keyword>
	<keyword>Endocrinology</keyword>
	<keyword>Critical Care</keyword>
</DOC>